Pure Global AI
ANVISA registration 80560310105Valid until Oct 24, 2035

SELF-TEST FOR GLUCOSE MONITORING IN INTERSTITIAL FLUID (PERCUTANEOUS) - SENSOR/TRANSMITTER

ANVISA Registration Number: 80560310105MEDLEVENSOHN COMÉRCIO E REPRESENTAÇÕES DE PRODUTOS HOSPITALARES LTDAMICROTECH MEDICAL (HANGZHOU) CO., LTD.Risk Class III
Device names
Technical name
SELF-TEST FOR GLUCOSE MONITORING IN INTERSTITIAL FLUID (PERCUTANEOUS) - SENSOR/TRANSMITTER
PT: AUTOTESTE PARA MONITORAMENTO DA GLICOSE EM LÍQUIDO INTERSTICIAL (PERCUTÂNEO) - SENSOR/TRANSMISSOR
Commercial name
Smart Medlevensohn 2.0 - Sensor Sistema de Monitoramento Contínuo de Glicose
Risk class
Class III
Registration details
Registration Number
80560310105
Process Number
25351096294202574
CNPJ
05343029000190
Company information
Manufacturing Country
China
PT: CHINA, REPÚBLICA POPULAR
Dates and status
Publication Date
Oct 24, 2025
Validity
24/10/2035
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for SELF-TEST FOR GLUCOSE MONITORING IN INTERSTITIAL FLUID (PERCUTANEOUS) - SENSOR/TRANSMITTER in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80560310105 and manufactured by MICROTECH MEDICAL (HANGZHOU) CO., LTD.. The registration is held by MEDLEVENSOHN COMÉRCIO E REPRESENTAÇÕES DE PRODUTOS HOSPITALARES LTDA with validity until Oct 24, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.